QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the fourth quarter 2024.
Press release date time: Wednesday, February 5, shortly after 22:05 Frankfurt time 21:05 London time 16:05 New York time.
Conference call date time: Thursday, February 6, at 16:00 Frankfurt time 15:00 London time 10:00 New York time.
Three options for joining the conference call
Register for call back connection Click here: Connect me
Service is available 15 minutes before the call starts
Dial-in by phone
U.S.: +1 646 828 8193
UK: +44 (0)330 165 4027
GER: +49 (0)69 6610 2480
Conference ID: 9237018
To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.
Access the audio webcast Click here:Access Webcast
A conference call replay will be available by using the following link:
https://event.webcasts.com/starthere.jsp?ei=1684130&tp_key=c56f1d6ba2
ContactIR@qiagen.com
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of September 30, 2024, QIAGEN employed more than 5,800 people in over 35 locations worldwide. Further information can be found at https://www.qiagen.com.
Source: QIAGEN N.V.
Category: Financial
View source version on businesswire.com: https://www.businesswire.com/news/home/20250115503089/en/
Contacts:
John Gilardi
Vice President, Head of Corporate Communications and Investor Relations
+49 2103 29 11711
+49 152 018 11711
+1 240 686 2222
Email: ir@qiagen.com
Domenica Martorana
Associate Director Investor Relations
+49 2103 29 11244
+49 152 018 11244
Email: ir@qiagen.com
